norstella-logo-white
Contact us

Refine results

refine

Resources

Toggle Filters
Article icon
Article

Connecting the dots with NorstellaLinQ

March 10, 2025
Norstella’s VP of thought leadership, Daniel Chancellor, was invited to share his perspectives on the proliferation of data with the leading publication The Medicine Maker. The timing was perfect, coming shortly after we launched NorstellaLinQ, the...
Read the article
Article icon
Article

Spotlight on South Korea: Innovation,...

March 4, 2025
In a series exploring trends across the APAC region, Norstella’s subject matter experts from key biopharma hubs delve into this year’s standout developments and share their outlook for 2025. South Korea has firmly established itself as...
Read the article
Infographic icon
Infographic

Breaking barriers in rare disease...

February 28, 2025
Bringing rare disease treatments from pipeline to patient Rare diseases affect more than 395 million people worldwide, yet only 5% have an FDA-approved treatment. The challenges of small patient populations, regulatory complexities, and limited clinical data...
Download the infographic
Article icon
Article

The ‘Doing now what patients...

February 27, 2025
Among all the corporate presentations at the 2025 J.P. Morgan Healthcare Conference, one small graphic from Roche (page 7), along with its purpose statement of “Doing now what patients need next”, stood out. The analysis was...
Read the article
Article icon
Article

Assessing current AI trends in...

February 13, 2025
Artificial intelligence (AI) has shifted from experimental projects to a valuable pharmaceutical research and development (R&D) asset. While the pace of adoption varies across the industry, AI is enabling organizations to address inefficiencies, reduce timelines, and...
Read the article
category
Case study

Unstructured EMR data expands cohort... Unstructured EMR data expands cohort identification by 1,500%

February 5, 2025
By using integrated EMR, lab and claims data, Panalgo was able to provide the manufacturer...
View resource
category
Case study

Powering unbiased outcomes research with... Powering unbiased outcomes research with longitudinal data

February 5, 2025
The Panalgo team linked its unstructured EMR data, powered by NorstellaLinQ, to its closed claims...
View resource
category
Article

Biopharma’s R&D engine and the... Biopharma’s R&D engine and the importance of looking east

January 28, 2025
One of the main topics of conversation at the beginning of 2025 is how pharma...
View resource
category
Article

Spotlight on India: A booming... Spotlight on India: A booming part of the global ecosystem

January 23, 2025
In a series exploring trends across the APAC region, Norstella’s subject matter experts from key...
View resource
category
Case study

Complex cohort identification fuels real-time... Complex cohort identification fuels real-time HCP targeting

January 13, 2025
Learn how one manufacturer used integrated claims, lab, EMR and coverage data to identify newly...
View resource
category
Ebook

The greatest opportunities to enhance... The greatest opportunities to enhance drug development in 2025

January 9, 2025
The pharma industry continues to persevere through talent shortages, supply chain disruptions, data challenges, and...
View resource
category
Article

Spotlight on Japan: A supportive... Spotlight on Japan: A supportive government but market share declines

December 19, 2024
In a series exploring trends across the APAC region, Norstella’s subject matter experts from key...
View resource
category
Case study

Unlocking value potential for a... Unlocking value potential for a client’s rare disease treatment

December 17, 2024
In this use case, learn how MMIT, powered by NorstellaLinQ, translated complex RWD into actionable...
View resource
category
Article

Harnessing the power of RWE... Harnessing the power of RWE to improve drug development

December 17, 2024
Real-world evidence (RWE) is becoming increasingly important in driving pharmaceutical innovations, as it helps researchers...
View resource
category
Case study

Addressing cost barriers and enhancing... Addressing cost barriers and enhancing medicare access strategies to improve commercialization strategy

December 17, 2024
In this use case, learn how MMIT, powered by NorstellaLinQ, translated complex RWD into actionable...
View resource
category
White paper

Innovation trends from R&D to... Innovation trends from R&D to market access

December 12, 2024
2024 has been an incredibly busy year for Norstella as its constituent organizations – Citeline,...
View resource
category
Report

Assessing AI transformation in pharma... Assessing AI transformation in pharma R&D: Current and future impact

December 5, 2024
Artificial intelligence (AI) has been one of the largest disruptors in drug development over the...
View resource